1. Home
  2. MNOV vs VGI Comparison

MNOV vs VGI Comparison

Compare MNOV & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • VGI
  • Stock Information
  • Founded
  • MNOV 2000
  • VGI 2012
  • Country
  • MNOV United States
  • VGI United States
  • Employees
  • MNOV N/A
  • VGI N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • VGI Investment Managers
  • Sector
  • MNOV Health Care
  • VGI Finance
  • Exchange
  • MNOV Nasdaq
  • VGI Nasdaq
  • Market Cap
  • MNOV 68.2M
  • VGI N/A
  • IPO Year
  • MNOV 2005
  • VGI N/A
  • Fundamental
  • Price
  • MNOV $1.25
  • VGI $7.92
  • Analyst Decision
  • MNOV Strong Buy
  • VGI
  • Analyst Count
  • MNOV 2
  • VGI 0
  • Target Price
  • MNOV $7.00
  • VGI N/A
  • AVG Volume (30 Days)
  • MNOV 14.8K
  • VGI 46.0K
  • Earning Date
  • MNOV 08-07-2025
  • VGI 01-01-0001
  • Dividend Yield
  • MNOV N/A
  • VGI 12.66%
  • EPS Growth
  • MNOV N/A
  • VGI N/A
  • EPS
  • MNOV N/A
  • VGI N/A
  • Revenue
  • MNOV N/A
  • VGI N/A
  • Revenue This Year
  • MNOV N/A
  • VGI N/A
  • Revenue Next Year
  • MNOV N/A
  • VGI N/A
  • P/E Ratio
  • MNOV N/A
  • VGI N/A
  • Revenue Growth
  • MNOV N/A
  • VGI N/A
  • 52 Week Low
  • MNOV $1.12
  • VGI $6.68
  • 52 Week High
  • MNOV $2.55
  • VGI $7.99
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 42.31
  • VGI 69.29
  • Support Level
  • MNOV $1.32
  • VGI $7.50
  • Resistance Level
  • MNOV $1.38
  • VGI $7.73
  • Average True Range (ATR)
  • MNOV 0.05
  • VGI 0.07
  • MACD
  • MNOV -0.00
  • VGI 0.02
  • Stochastic Oscillator
  • MNOV 30.77
  • VGI 89.36

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

Share on Social Networks: